The soluble fraction of
polysaccharides from cabernet franc red wine (
SFP) previously showed antitumoral effects by modulating the immune system. The present study tested the hypothesis that the
SFP can regulate CYPs in vitro in HepG2 cells and in vivo in Walker-256
tumor-bearing rats. The
SFP was used in the following protocols: (i) solid
tumor, (ii) liquid
tumor, and (iii) chemopreventive solid
tumor. The
SFP reduced solid
tumor growth in both solid
tumor protocols but did not inhibit liquid
tumor development. The
SFP reduced total CYP levels in the solid and liquid
tumor protocols and reduced the gene expression of
Cyp1a1 and
Cyp2e1 in rats and
CYP1A2 in HepG2 cells. An increase of N-
acetylglucosaminidase activity was observed in all
SFP-treated rats, and TNF-α levels increased in the solid
tumor protocol in the vehicle,
SFP, and
vincristine (positive control) groups. The chemopreventive solid
tumor protocol did not modify CYP levels in the liver or intestine or N-
acetylglucosaminidase and
myeloperoxidase activity in the liver. The in vitro digestion and nuclear magnetic resonance analyses suggested that
SFP was minimally modified in the gastrointestinal system. In conclusion,
SFP inhibited CYPs both in vivo and in vitro, likely as a result of its immunoinflammatory actions.